Device / Technology News

RSS

Data demonstrates overall radiation with digital mammography is less than film mammography

Data from one of the largest mammography trials in history demonstrates that overall the radiation dose associated with digital mammography is significantly lower (averaging 22 percent lower) than that of conventional film mammography and that the reduction could be greater in women with larger and denser breasts, according to a study published in the February issue of the American Journal of Roentgenology.

21 Jan 2010

World’s first Cs-131 implant for colorectal cancer performed at Weill Cornell Medical Center

IsoRay, Inc., announced today that on October 10, 2009, Dr. Bhupesh Parashar, Dr. A Gabriella Wernicke and Dr. KS Clifford Chao from the Department of Radiation Oncology, and Dr. Jeffery Milsom from the Department of Gastrointestinal Surgery, at Weill Cornell Medical Center performed the world’s first Cesium-131(Cs-131) implant for the treatment of colorectal cancer.

21 Jan 2010

Depomed receives second $500,000 milestone payment from Covidien

Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed’s Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.

21 Jan 2010

ResCare chooses GuardianEdge to assist in HIPAA compliance

GuardianEdge, the leader in endpoint data protection, today announced that ResCare, one of the nation's leading providers of services to people with disabilities and the elderly, has selected GuardianEdge to secure the company's more than 6,000 endpoint devices and to assist in Health Insurance Portability and Accountability Act (HIPAA) compliance. To ensure that sensitive patient data is secure, ResCare has deployed GuardianEdge Hard Disk Encryption, GuardianEdge Removable Storage Encryption and GuardianEdge Device Control.

21 Jan 2010

Phase Forward releases Empirica Signal version 7.2 signal detection and management software

Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company’s flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward’s Empirica Suite of pharmacovigilance and risk management products.

21 Jan 2010

Rules for patient data security remain widely unenforced

"As the federal government prepares to spend up to $27 billion in stimulus funds to promote electronic medical records, a health technology industry survey suggests that a number of hospitals, health clinics, and insurance firms are violating federal security rules on patient data and putting sensitive health information at risk," The Center for Public Integrity reports.

21 Jan 2010

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

Genomic Health, Inc. today announced worldwide commercial availability of its Oncotype DX® colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at the 2009 American Society of Clinical Oncology (ASCO) meeting.

21 Jan 2010

Health IT news: Grassley queries hospitals, Microsoft's CEO sees need to boost tech for doctors, hospitals

Modern Healthcare: "Sen. Chuck Grassley (R-Iowa) has sent a letter asking 31 hospitals to report on their relationships with healthcare IT vendors, focusing on errors caused by IT systems and on so-called 'gag order or non-disclosure clauses' in vendor contracts that might prohibit the hospitals from disclosing information about system flaws." Grassley made a similar request to the IT vendors themselves last fall, and said his new letter was prompted by concern about taxpayers' investment in health IT as part of the economic stimulus (Conn, 1/20).

21 Jan 2010

Zirmed achieves EHNAC HNAP accreditation

ZirMed®, a leading national provider of revenue cycle management solutions for healthcare providers, announced yesterday it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions, and indicates compliance with industry-established standards and HIPAA regulations.

21 Jan 2010

Enrollment complete in Vertos Medical's U.S. IRB I "mild" procedure Patient Outcomes Trial

Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.

21 Jan 2010

Applied Biosystems' AmpFℓSTR MiniFiler PCR Amplification Kit receives NDIS approval

Applied Biosystems, part of Life Technologies Corporation today announced that its AmpFℓSTR® MiniFiler™ PCR Amplification Kit has been approved for inclusion in the National DNA Index System (NDIS), a United States Federal Bureau of Investigation database that facilitates the electronic comparison and exchange of DNA profiles between participating local, county, state, and federal law enforcement agencies and forensic laboratories.

21 Jan 2010

Meridian Bioscience announces record first-quarter net sales of $42.5M

Net sales for the first quarter of fiscal 2010 were $42,457,000 as compared to $34,293,000 for the same period of the prior fiscal year, an increase of 24%. Net earnings for the first quarter of fiscal 2010 were $8,921,000 or $0.22 per diluted share, both increases of 10% over the first quarter of fiscal 2009. Diluted common shares outstanding for fiscal 2010 and 2009 were 41,185,000 and 41,125,000, respectively.

21 Jan 2010

Exalenz Bioscience finalizes production of its BreathID System for detecting H. pylori bacteria

Exalenz Bioscience has finalized production of the BreathID® and is preparing to ship the first devices and kits that are used in the detection of Helicobacter pylori bacteria. Additionally, in preparation for its American launch, the company is in the process of establishing national distribution channels. The company has recently announced the appointment of Mr. Dennis Boyle as Vice-President and National Manager in the USA. In his previous position, Mr. Boyle was director of sales and marketing to medical laboratories for Siemens USA.

21 Jan 2010

Abaxis' new CRP assay receives FDA marketing clearance

Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S. Food and Drug Administration (FDA) has granted 510K marketing clearance of the new C-Reactive Protein (CRP) assay when used by healthcare professionals in conjunction with the Piccolo Xpress™ point-of-care analyzer.

21 Jan 2010

Efficacy of neurofeedback in treating ADD/ADHD

On January 22, the Potomac Institute for Policy Studies will present a guest lecture by Don DuRousseau, founder and CEO of Human Bionics LLC, a neurotechnology company specializing in brain-computer interface (BCI) systems. Mr. DuRousseau will explore the use of neurotechnology techniques, including the increasingly popular neurofeedback, as a treatment for ADD/ADHD.

21 Jan 2010

Cord Blood America to provide BioE's PrepaCyte CB Processing System for its Las Vegas operations

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has contracted with BioE, St. Paul, Minnesota, to provide the newest "state of the art" cord blood processing systems for its Las Vegas operations.

21 Jan 2010

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider of biologic packaging products for research and clinical blood and cell-based therapies, today announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosol® cell and tissue storage/transport media and CryoStor™ cryopreservation media.

21 Jan 2010

First DataBank signs licensing agreement with SIS

First DataBank, a leading provider of drug databases that help drive patient safety, and Surgical Information Systems (SIS), a provider of feature-rich perioperative software solutions, announced today they have signed an agreement whereby First DataBank will license its suite of comprehensive drug information and associated developer software to Surgical Information Systems to enable the integration of new functionality for drug screening, dosing and documentation within the SIS suite of interoperable surgery solutions.

21 Jan 2010

The Pennsylvania State University to use Click Commerce's eResearch Portal software

Click Commerce, the pioneer in customer-configurable solutions for the business of research, announced today that The Pennsylvania State University will use the company’s eResearch Portal software to fully automate researcher disclosures of outside financial interests.

21 Jan 2010

Phoenix Controls announces the introduction of APM2

Phoenix Controls, a Honeywell International business, today announced the introduction of the Advanced Pressure Monitor II (APM2), a device that monitors very low differential pressure between rooms.

21 Jan 2010

Device / Technology News

Data demonstrates overall radiation with digital mammography is less than film mammography

World’s first Cs-131 implant for colorectal cancer performed at Weill Cornell Medical Center

Depomed receives second $500,000 milestone payment from Covidien

ResCare chooses GuardianEdge to assist in HIPAA compliance

Phase Forward releases Empirica Signal version 7.2 signal detection and management software

Rules for patient data security remain widely unenforced

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

Health IT news: Grassley queries hospitals, Microsoft's CEO sees need to boost tech for doctors, hospitals

Zirmed achieves EHNAC HNAP accreditation

Enrollment complete in Vertos Medical's U.S. IRB I "mild" procedure Patient Outcomes Trial

Applied Biosystems' AmpFℓSTR MiniFiler PCR Amplification Kit receives NDIS approval

Meridian Bioscience announces record first-quarter net sales of $42.5M

Exalenz Bioscience finalizes production of its BreathID System for detecting H. pylori bacteria

Abaxis' new CRP assay receives FDA marketing clearance

Efficacy of neurofeedback in treating ADD/ADHD

Cord Blood America to provide BioE's PrepaCyte CB Processing System for its Las Vegas operations

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

First DataBank signs licensing agreement with SIS

The Pennsylvania State University to use Click Commerce's eResearch Portal software

Phoenix Controls announces the introduction of APM2

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News